Conferences Alkermes is attending in 2026
Alkermes is listed at 2 conferences on Tnuki's calendar in 2026: SfN 2026 (on the program) and Discovery on Target 2026 (on the attendee list). Alkermes makes medicines for addiction, schizophrenia, depression, and other central nervous system disorders. As of Oct 17, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
Neuroscience 2026 (SfN Annual Meeting)World’s largest neuroscience gatheringOfficial site |
Washington, DC ~21k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 2 posters Attendee mix: Mostly academic; neuroscience PIs, postdocs and students, some industry neuroscientists
Attending
|
Open the guide Search and filter attendees |
Discovery on Target 2026Target discovery biologists & chemistsOfficial site |
Past Boston, MA ~1.1k attendees | On the attendee listNo booth or sponsorship in the organizer’s published lists Listed in the Discovery on Target 2026 guide; no booth or program details yet
Attendee mix: Mostly biopharma; target discovery biologists, medicinal chemists and discovery group leaders, some academics
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Alkermes’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.
Instantly find decision makers at Alkermes
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!